WT1 Gene Transcript Assay for Relapse in Acute Leukemia after Transplantation

References

• Call, KM., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., et al. (1990) "Isolation and characterization of a zinc finger polypeptide gene at human chromosome 11 Wilms' tumor locus", Cell, 60, 509–520.
   Google Scholar
• Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H. and Bruns, G.A. (1990) "Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping", Nature, 343, 774–778.
   Google Scholar
• Rauscher, F.J. 3rd. (1993) "The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor", FASEB J., 7, 896–903.
   Google Scholar
• Rose, E.A., Glaser, T., Jones, C., Smith, C.L., Lewis, W.H., Call, K.M., et al. (1990) "Complete physical map of the WAGR region of 1 1p13 localizes a candidate Wilms' tumor gene", Cell, 60, 495 — 508.
   Google Scholar
• Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., et al. (1994) "WTI as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia", Blood, 84, 3071–3079.
   Google Scholar
• Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., et al. (1997) "Aberrant overexpression of the Wilms tumor gene (WTI) in human leukemia", Blood, 89, 1405–1412.
   Google Scholar
• Miwa, H., Beran, M. and Saunders, G.F. (1992) "Expression of the Wilms' tumor gene (WTI) in human leukemias", Leukemia, 6, 405 — 409.
   Google Scholar
• Miyagi, T., Ahuja, H., Kubota, T., Kubonishi, I., Koeffler, H.P. and Miyoshi, I. (1993) "Expression of the candidate Wilms' tumor gene, WTI, in human leukemia cells", Leukemia, 7, 970–977.
   Google Scholar
• Brieger, J., Weidmann, E., Fenchel, K., Mitrou, P.S., Hoelzer, D. and Bergmann, L. (1994) "The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells", Leukemia, 8, 2138 — 2143.
   Google Scholar
• Menssen, H.D., Renkl, H.J., Rodeck, U., Maurer, J., Notter, M., Schwartz, S., et al. (1995) "Presence of Wilm's tumor gene (wt 1) transcripts and the WT1 nuclear protein in the majority of human acute leukemia", Leukemia, 9, 1060–1069.
   Google Scholar
• Hosen, N., Sonoda, Y., Oji, Y., Kimura, T., Minamiguchi, H., Tamaki, H., et al. (2002) "Very low frequencies of human normal CD34 ± hematopoietic progenitor cells express the Wilms' tumor gene WTI at the levels comparable to those in leukemia cells", Br. J. Haematol., 116, 409–420.
   Google Scholar
• Sykes, P.J., Neoh, S.H., Brisco, M.J., Hughes, E., Condon, J. and Morley, A.A. (1992) "Quantitation of targets for PCR by use of limiting dilution", Biotechniques, 13, 444–449.
   Google Scholar
• Gilliland, G., Perrin, S., Blanchard, K. and Bunn, H.F. (1990) "Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction", Proc. Natl. Acad. Sci. U S A, 87, 2725–2729.
   Google Scholar
• Kreuzer, K.A., Saborowski, A., Lupberger, J., Appelt, C., Na, I.K., le Coutre, P., et al. (2001) "Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias", Br. J. Haematol., 114, 313–318.
   Google Scholar
• Siehl, J.M., Thiel, E., Leben, R., Reinwald, M., Knauf, W. and Menssen, H.D. (2002) "Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts", Bone Marrow Transplant, 29, 379 — 381.
   Google Scholar
• Cilloni, D., Gottardi, E., De Micheli, D., Serra, A., Volpe, G., Messa, F., et al. (2002) "Quantitative assessment of WT1 expression by real time quantitative PCR may be a usaful tool for monitoring minimal residual disease in acute leukemia patients", Leukemia, 16, 2115 — 2121.
   Google Scholar
• Tamaki, H., Mishima, M., Kawakami, M., Tsuboi, A., Kim, E.H., Hosen, N., et al. (2003) "Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms' tumor gene (WT1)", Int. J. Hematol., 78, 349 — 356.
   Google Scholar
• Suzuki, T., Higgins, P.J. and Crawford, D.R. (2000) "Control selection for RNA quantitation", Biotechniques, 29, 332— 337.
   Google Scholar
• Lossos, IS., Czerwinski, D.K., Wechser, M.A. and Levy, R. (2003) "Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies", Leukemia, 17, 789–795.
   Google Scholar
• Lion, T. (2001) "Debate round table on RT-PCR controls: concluding remarks and mini-review", Leukemia, 15, 1033— 1037.
   Google Scholar
• Brieger, J., Weidmann, E., Maurer, U., Hoelzer, D., Mitrou, P.S. and Bergmann, L. (1995) "The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR", Ann. Oncol., 6, 811–816.
   Google Scholar
• Tamaki, H., Ogawa, H., Ohyashiki, K., Ohyashiki, J.H., Iwama, H., Inoue, K, et al. (1999) "The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes", Leukemia, 13, 393–399.
   Google Scholar
• Greenberg, P., Cox, C., LeBeau, M.M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., et al. (1997) "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, 2079 — 2088.
   Google Scholar
• Cilloni, D., Gottardi, E., Messa, F., Fava, M., Scaravaglio, P., Bertini, M., et al. (2003) "Piedmont Study Group on Myleodys-plastic Syndromes. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes", J. Clin. Oncol., 21, 1988 — 1995.
   Google Scholar
• Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., et al. (1996) "Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis", Blood, 87, 2878 — 2884.
   Google Scholar
• Inoue, K., Tamaki, H., Ogawa, H., Oka, Y., Soma, T., Tatekawa, T., et al. (1998) "Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells", Blood, 91, 2969 — 2976.
   Google Scholar
• Oji, Y., Ogawa, H., Tamaki, H., Oka, Y., Tsuboi, A., Kim, E.H., et al. (1999) "Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth", Jpn. J. Cancer Res., 90, 194–204.
   Google Scholar
• Oji, Y., Yamamoto, H., Nomura, M., Nakano, Y., Ikeba, A., Nakatsuka, S., et al. (2003) "Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma", Cancer Sci., 94, 712 — 717.
   Google Scholar
• Silberstein, G.B., Van Horn, K., Strickland, P., Roberts, C.T. Jr. and Daniel, C.W. (1997) "Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer", Proc. Natl. Acad. Sci. USA, 94, 8132–8137.
   Google Scholar
• Loeb, D.M. and Sukumar, S. (2002) "The role of WT1 in oncogenesis: tumor suppressor or oncogene?", Int. J. Hematol., 76, 117— 126.
   Google Scholar
• Baird, P.N. and Simmons, PJ. (1997) "Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis", Exp. Hematol., 25, 312— 320.
   Google Scholar
• Fraizer, G.C., Patmasiriwat, P., Zhang, X. and Saunders, G.F. (1995) "Expression of the tumor suppressor gene WT1 in both human and mouse bone marrow", Blood, 86, 4704–4706.
   Google Scholar
• Ogawa, H., Tamaki, H., Ikegame, K., Soma, T., Kawakami, M., Tsuboi, A., et al. (2003) "The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia", Blood, 101, 1698 — 1704.
   Google Scholar
• Tamaki, H., Ogawa, H., Inoue, K., Soma, T., Yamagami, T., Miyake, S., et al. (1996) "Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia". Blood, 88, 4396–4398.
   Google Scholar
• Schmid, D., Heinze, G., Linnerth, B., Tisljar, K., Kusec, R., Geissler, K., et al. (1997) "Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia", Leukemia, 11, 639–643.
   Google Scholar
• Elmaagacli, A.H., Beelen, D.W., Trenschel, R. and Schaefer, U.W. (2000) "The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow transplantation or peripheral blood stem cell transplantation", Bone Marrow Transplant., 25, 91–96.
   Google Scholar
• Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Tani, Y., Tatekawa, T., et al. (1996) "Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels", Blood, 88, 2267 — 2278.
   Google Scholar
• Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E., et al. (1997) "High levels of Wilms' tumor gene (wtl) mRNA in acute myeloid leukemias are associated with a worse long-term outcome", Blood, 90,1217 — 1225.
   Google Scholar
• Lin, F., van Rhee, F., Goldman, J.M. and Cross, N.C. (1996) "Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation", Blood, 87, 4473–4478.
   Google Scholar
• Cilloni, D., Gottardi, E., Fava, M., Messa, F., Carturan, S., Busca, A., et al. (2003) "Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection", Blood, 102, 773–774.
   Google Scholar
• Carlens, S., Ringden, 0., Aschan, J., Hagglund, H., Ljungman, P., Mattsson, J., et al. (1998) "Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination", Clin. Transplant., 84–92.
   Google Scholar
• Giralt, S.A. and Champlin, RE. (1994) "Leukemia relapse after allogeneic bone marrow transplantation: a review", Blood, 84, 3603— 3612.
   Google Scholar
• Thomas, ED., Buckner, C.D., Banaji, M., Clift, R.A., Fefer, A., Flournoy, N., et al. (1977) "One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation", Blood, 49, 511— 533.
   Google Scholar
• Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., et al. (1995) "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia", Blood, 86, 2041–2050.
   Google Scholar
• Drobyski, W.R., Keever, CA., Roth, M.S., Koethe, S., Hanson, G., McFadden, P., et al. (1993) "Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose", Blood, 82, 2310–2318.
   Google Scholar
• Porter, DL., Roth, M.S., McGarigle, C., Ferrara, J.L. and Antin, J.H. (1994) "Induction of graft-versus-host disease as immunother-apy for relapsed chronic myeloid leukemia", N. Engl. J. Med., 330, 100–106.
   Google Scholar
• Collins, R.H. Jr., Shpilberg, 0., Drobyski, W.R., Porter, DL., Giralt, S., Champlin, R., et al. (1997) "Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation", J. Clin. Oncol., 15, 433–444.
   Google Scholar
• Bader, P., Klingebiel, T., Schaudt, A., Theurer-Mainka, U., Handgretinger, R., Lang, P., et al. (1999) "Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children", Leukemia, 13, 2079 — 2086.
   Google Scholar
• Dazzi, F., Szydlo, R.M., Cross, N.C., Craddock, C., Kaeda, J., Kanfer, E., et al. (2000) "Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia", Blood, 96, 2712–2716.
   Google Scholar
• Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., et al. (1996) "Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation", Blood, 87, 2195–2204.
   Google Scholar
• Ogawa, H., Tsuboi, A., Oji, Y., Tamaki, H., Soma, T., Inoue, K., et al. (1998) "Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay", Bone Marrow Transplant., 21, 525–527.
   Google Scholar
• Weaver, C.H., Clift, R.A., Deeg, H.J., Storb, R., Appelbaum, FR., Bensinger, W., et al. (1994) "Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia", Bone Marrow Transplant., 14, 885–893.
   Google Scholar